Step Down Beds Framework - NHS Bedfordshire, Luton and Milton Keynes ICB

Award

Value

£36,000,000

Classifications

  • Health services

Tags

  • award

Submission Deadline

3 years ago

Published

2 years ago

Description

NHS Bedfordshire, Luton and Milton Keynes Integrated Care Board (BLMK ICB) invited expressions of interest from suitably qualified providers D2A Step-down ("the service"), to be delivered across the population of Bedfordshire, Luton and Milton Keynes.

An advert (ref: 20220718173249-68205) was published on this Contracts Finder portal and a Contract Notice (ref: 2022/S 000-019588) on the Find-a-Tender Service portal was published on 18th July 2022 for this opportunity.

The aim of commissioning step down beds was to provide a community bed for patients who have had an acute inpatient episode, but who are not yet ready to go home, and who need a period of recuperation and recovery. This cohort also includes people who may require a residential long-term placement. This may be because they need a further period of recovery before being able to engage in active rehabilitation; they may need some additional rehabilitation therapy before being able to return home: or it may be that they have yet to complete their Continuing Healthcare or Social Care Assessments for their long-term care needs prior to discharge home or to a long-term placement.

Contracts are awarded on a framework agreement with multiple providers. The total number of providers within the framework is based on the capacity of providers however it was expected to be between 10-15 based on the minimum capacity levels identified. Providers are able to supply beds across multiple sites and localities however each site must meet the required minimum capacity levels.

The contract is for an initial period of 3 years from 1st April 2023 to 31st March 2026, with an option to extend for up to a further two years until 31st March 2028 at the discretion of the commissioner. It is important to note here that the contract value and activity levels were derived based on past experience. There is no guarantee that they will remain at these levels in the future. They may increase or decrease. The actual contract value and activity levels may differ during the period of service provision due to factors beyond the Commissioner'(s) control such as increase/decrease in population of the local area, closure of other nearby NHS health organisations due to unforeseen reasons, patient's experience/preference etc. 

The Commissioner reserves the right to open future windows at their discretion for additional providers if increased capacity is required. These windows may be opened at any time subject to the need and discretion of the Commissioner.

Similar Contracts

Open

National Clinical Audit of Seizures and Epilepsies in Children and Young People

The contract will initially be delivered for NHS-funded care in England, Wales, and publicly funded care in Jersey for a period of 3 years, at a maximum total budget of up to £1,262,160 GBP including VAT, £1,051,800 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £1,262,160 GBP including VAT, £1,051,800 GBP excluding VAT. The maximum budget ‘core’ value is £1,262,160 GBP including VAT, £1,051,800 GBP excluding VAT excludes the potential two year extension and aspirational intent as described in section 14 of Annex A - Service Specification. Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £9,737,980 GBP including VAT, £8,114,983 GBP excluding VAT. The role of a national clinical audit is to stimulate healthcare improvement through the provision of high quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and there is a shared understanding of what good care looks like. The overarching aim is to stimulate improvements in care for children and young people receiving care for seizures and epilepsies by measuring variations in quality, experience and outcomes of NHS care in England and Wales. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly and appropriate tools, support and guidance accompany the data outputs. The intent is for all of these features of the audit to be implemented and improved during the period of this contract. The audit supplier will work with commissioners and funders to create a coherent strategy for how improvement goals will support the organisations in the CYP epilepsy care pathway to try and achieve them. This audit programme is expected to: O develop a robust, high quality audit designed around key quality indicators likely to best support local and national quality improvement O achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate O enable improvements through the provision of timely, high quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, commissioner, MDT, possibly consultant or clinical team level and other levels of reporting O engage CYP, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit O consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract O ensure robust methodological and statistical input at all stages of the audit O identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly O provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data O utilise strong and effective project and programme management to deliver audit outputs on time and within budget; and O develop and maintain strong engagement with local clinicians, networks, commissioners, CYP, their families and carers, and charity and community support groups, in order to drive improvements in services for CYP. Further details of the existing audit can be found at: https://www.rcpch.ac.uk/work-we-do/clinical-audits/epilepsy12 To respond to this opportunity, please visit https://www.delta-esourcing.com/respond/CUF939U663 To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=998895267

Katy Reed

Published 12 hours ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete